Neil Abdollahian Insider Trading $CDTX Cidara Therapeutics, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Neil Abdollahian.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Neil Abdollahian. Neil Abdollahian is Chief Business Officer in Cidara Therapeutics, Inc. ($CDTX).
Neil Abdollahian in Cidara Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Neil Abdollahian: Chief Business Officer
Holdings: 51,248 shares
Current Value: $491,981
Latest Transaction: Mar 19 2021
$CDTX Market Capitalization: $167.56M
$CDTX Previous Close: $9.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Neil Abdollahian in Cidara Therapeutics, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.55 | 150,000 | 382,500 | 150,000 | |
| Mar 19 2021 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.55 | 150,000 | 382,500 | 150,000 | |
| Mar 23 2020 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 1.98 | 115,000 | 227,700 | 115,000 | |
| Jan 06 2020 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Sell | S | 3.42 | 2,340 | 8,003 | 51,248 | 53.6 K to 51.2 K (-4.37 %) |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 3,704 | 9,075 | 3,704 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 29,629 | 72,591 | 29,629 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | D | 7.80 | 50,000 | 390,000 | 0 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 9,721 | 23,816 | 9,721 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.45 | 56,945 | 139,515 | 56,945 | |
| Dec 20 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | D | 10.45 | 100,000 | 1,045,000 | 0 | |
| Oct 03 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Sell | S | 1.98 | 7,284 | 14,422 | 49,588 | 56.9 K to 49.6 K (-12.81 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 4,900 | 0 | 9,100 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 17,500 | 0 | 7,500 | |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 4,900 | 0 | 56,872 | 52 K to 56.9 K (+9.43 %) |
| Sep 16 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 17,500 | 0 | 51,972 | 34.5 K to 52 K (+50.77 %) |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 22 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 2.61 | 77,000 | 200,970 | 77,000 | |
| Mar 08 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Sell | S | 2.44 | 2,300 | 5,612 | 30,472 | 32.8 K to 30.5 K (-7.02 %) |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 14,000 | 0 | 14,000 | |
| Feb 01 2019 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 6,000 | 0 | 32,772 | 26.8 K to 32.8 K (+22.41 %) |
| Apr 02 2018 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 4.00 | 70,000 | 280,000 | 70,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | M | 0.00 | 25,000 | 0 | 25,000 | |
| Sep 19 2017 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Grant | A | 0.00 | 15,000 | 0 | 20,421 | 5.4 K to 20.4 K (+276.70 %) |
| Jul 05 2016 | CDTX | Cidara Therapeutic ... | Abdollahian Neil | Chief Business Offi ... | Option Exercise | A | 10.45 | 100,000 | 1,045,000 | 100,000 |
Page: 1